Skip to main content
. 2012 Apr;7(4):565–572. doi: 10.2215/CJN.12391211

Table 2.

ACEi or ARB use among elderly CKD patients with diabetes or proteinuria

Cohort n Standard Prompt, n (%) Enhanced Prompt, n (%) Intraclass Correlation Coefficient (P Value) Relative Risk (95% Confidence Interval)
eGFR <60 ml/min per 1.73 m2 5444 1932 (77.1) 2260 (76.9) 0.020 (<0.001) 1.00 (0.96–1.04)
eGFR <30 ml/min per 1.73 m2 483 161 (72.2) 208 (80.0) <0.001 (0.497) 1.13 (1.03–1.24)

Percentages represent patients with outcome out of the number of patients in the subgroup of interest, irrespective of baseline ACEi/ARB use. ACEi, angiotensin converting enzyme inhibitor; ARB, angiotensin receptor blocker; eGFR, estimated GFR.